Docetaxel Provectis 20 mg/1 ml

Docetaxel Provectis 20 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 70427. The authorisation holder is PROVECTIS HEALTHCARE AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 January 2026 and the authorisation is limited until 11 January 2031. ATC code L01CD02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 70427
  • ATC L01CD02
  • Synthetic medicines
Authorisation data
Authorisation number70427
NameDocetaxel Provectis 20 mg/1 ml
Full nameDocetaxel Provectis 20 mg/1 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderPROVECTIS HEALTHCARE AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01CD02
First authorisation12 January 2026
Authorisation validity11 January 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Docetaxel Provectis 20 mg/1 ml, Konzentrat zur Herstellung einer InfusionslösungA12 January 2026
2Docetaxel Provectis 80 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungA12 January 2026
3Docetaxel Provectis 160 mg/8 ml, Konzentrat zur Herstellung einer InfusionslösungA12 January 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01CD0207.16.1.A
21Durchstechflasche(n)L01CD0207.16.1.A
31Durchstechflasche(n)L01CD0207.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Docetaxel Provectis 20 mg/1 ml authorised in Switzerland?

Yes. Docetaxel Provectis 20 mg/1 ml is authorised by Swissmedic under authorisation number 70427, data as of 01 September 2026. The authorisation is limited until 11 January 2031.

Which dispensing category does Docetaxel Provectis 20 mg/1 ml have?

Docetaxel Provectis 20 mg/1 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Docetaxel Provectis 20 mg/1 ml?

The authorisation holder is PROVECTIS HEALTHCARE AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com